Stability and solubility engineering of the EphB4 tyrosine kinase catalytic domain using a rationally designed

R C Overman1, I Green, C M Truman

  • 1Discovery Sciences, AstraZeneca PLC, Alderley Park, Cheshire SK10 4TG, UK.